These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 15738751)

  • 1. Maintenance treatment of severe tardive dyskinesia with clozapine: 5 years' follow-up.
    Louzã MR; Bassitt DP
    J Clin Psychopharmacol; 2005 Apr; 25(2):180-2. PubMed ID: 15738751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clozapine efficacy in tardive dyskinesia in schizophrenic patients.
    Bassitt DP; Louzã Neto MR
    Eur Arch Psychiatry Clin Neurosci; 1998; 248(4):209-11. PubMed ID: 9810484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New strategies for old problems: tardive dyskinesia (TD). Review and report on severe TD cases treated with clozapine, with 12, 8 and 5 years of video follow-up.
    Larach VW; Zamboni RT; Mancini HR; Mancini RR; Gallardo RT
    Schizophr Res; 1997 Dec; 28(2-3):231-46. PubMed ID: 9468357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clozapine-induced tardive dyskinesia in schizophrenic patients taking clozapine as a first-line antipsychotic drug.
    Li CR; Chung YC; Park TW; Yang JC; Kim KW; Lee KH; Hwang IK
    World J Biol Psychiatry; 2009; 10(4 Pt 3):919-24. PubMed ID: 19995222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clozapine treatment for neuroleptic-induced tardive dyskinesia, parkinsonism, and chronic akathisia in schizophrenic patients.
    Spivak B; Mester R; Abesgaus J; Wittenberg N; Adlersberg S; Gonen N; Weizman A
    J Clin Psychiatry; 1997 Jul; 58(7):318-22. PubMed ID: 9269253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia.
    McGrath JJ; Soares KV
    Cochrane Database Syst Rev; 2000; (2):CD000459. PubMed ID: 10796546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tardive dyskinesia, clozapine, and treatment response.
    Dalack GW; Becks L; Meador-Woodruff JH
    Prog Neuropsychopharmacol Biol Psychiatry; 1998 May; 22(4):567-73. PubMed ID: 9682273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clozapine and tardive dyskinesia in patients with schizophrenia: A systematic review.
    Pardis P; Remington G; Panda R; Lemez M; Agid O
    J Psychopharmacol; 2019 Oct; 33(10):1187-1198. PubMed ID: 31347436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clozapine for tardive dyskinesia in adolescents.
    Levkovitch Y; Kronenberg J; Kayser N; Zvyagelski M; Gaoni B; Gadoth N
    Brain Dev; 1995; 17(3):213-5. PubMed ID: 7573764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of relapsed tardive dyskinesia due to clozapine dose reduction.
    Uzun O; Cansever A; Ozsahin A
    Int Clin Psychopharmacol; 2001 Nov; 16(6):369-71. PubMed ID: 11712627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clozapine Monotherapy as a Treatment for Antipsychotic-Induced Tardive Dyskinesia: A Meta-Analysis.
    Mentzel TQ; van der Snoek R; Lieverse R; Oorschot M; Viechtbauer W; Bloemen O; van Harten PN
    J Clin Psychiatry; 2018 Sep; 79(6):. PubMed ID: 30257080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An assessment of emergent tardive dyskinesia and existing dyskinesia in patients receiving long-acting, injectable risperidone: results from a long-term study.
    Gharabawi GM; Bossie CA; Zhu Y; Mao L; Lasser RA
    Schizophr Res; 2005 Sep; 77(2-3):129-39. PubMed ID: 15913962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of tardive dyskinesia and tardive dystonia in African Caribbean patients on long-term antipsychotic treatment: the Curaçao extrapyramidal syndromes study V.
    van Harten PN; Hoek HW; Matroos GE; van Os J
    J Clin Psychiatry; 2006 Dec; 67(12):1920-7. PubMed ID: 17194270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of clozapine on caudate nucleus volume in schizophrenic patients previously treated with typical antipsychotics.
    Scheepers FE; de Wied CC; Hulshoff Pol HE; van de Flier W; van der Linden JA; Kahn RS
    Neuropsychopharmacology; 2001 Jan; 24(1):47-54. PubMed ID: 11106875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Response to Clozapine and Its Clinical Correlates in the Treatment of Tardive Movement Syndromes: A Naturalistic Observational Study in Patients With Psychotic Disorders.
    Lee D; Baek JH; Bae M; Choi Y; Hong KS
    J Clin Psychopharmacol; 2019; 39(6):591-596. PubMed ID: 31688397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No difference in the effect of biperiden and amantadine on parkinsonian- and tardive dyskinesia-type involuntary movements: a double-blind crossover, placebo-controlled study in medicated chronic schizophrenic patients.
    Silver H; Geraisy N; Schwartz M
    J Clin Psychiatry; 1995 Apr; 56(4):167-70. PubMed ID: 7713856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can atypical antipsychotics improve tardive dyskinesia associated with other atypical antipsychotics? Case report and brief review of the literature.
    Peritogiannis V; Tsouli S
    J Psychopharmacol; 2010 Jul; 24(7):1121-5. PubMed ID: 19395427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of clozapine on tardive dyskinesia.
    Lieberman JA; Saltz BL; Johns CA; Pollack S; Borenstein M; Kane J
    Br J Psychiatry; 1991 Apr; 158():503-10. PubMed ID: 1675900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High plasma clozapine levels in tardive dyskinesia.
    Pollack S; Lieberman J; Kleiner D; Szymanski S; Kane J; Borenstein M; Cooper T
    Psychopharmacol Bull; 1993; 29(2):257-62. PubMed ID: 8290674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of aripiprazole in tardive dyskinesia: an open label study of six cases.
    Rajarethinam R; Dziuba J; Manji S; Pizzuti A; Lachover L; Keshavan M
    World J Biol Psychiatry; 2009; 10(4 Pt 2):416-9. PubMed ID: 19492247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.